ART OF THE KILL

In response to the first wave of the COVID-19 pandemic in 2020, Dr. Roland Hetényi and Dr. Daniel Hanna, newly graduated doctors, founded RoLink Biotechnology Ltd. with the mission to bolster pandemic defense through rapid domestic innovation. With a grant of 350,000 EUR from the COVID Fund, we swiftly provided critical data to the Ministry within a month. As a key strategic partner of the National Laboratory of Virology, the only BSL-4 laboratory in the central EU region, we developed five innovative technologies applicable to any virus. Our groundbreaking achievement includes the UV inactivation of the coronavirus at the laboratory level, addressing the severe capacity constraints of BSL-4 facilities. Additionally, we devised a diagnostic procedure for convalescent plasma therapy and demonstrated in animal experiments that UV-inactivated coronavirus can serve as a viable vaccine base. We successfully navigated university-industry collaboration under challenging conditions and are now in advanced negotiations with major biotech companies, including CEVA Hungary, for vaccine technology development, and ThermoFisher, for the commercialization of our technologies. Furthermore, we serve as a subcontractor for the European Defence Fund, contributing to the rapid response and building of a European biodefense system. Our collaboration with the Hungarian Military positions them as both a key collaborator and a future customer for our technologies.